Company Description

Positivo Biotechnology is developing non-viral DNA gene delivery and expression systems for treating various diseases, including cystic fibrosis. Their technology aims to overcome challenges in traditional gene therapies, such as immune responses and toxicity, by delivering and expressing DNA-encoded therapeutics more safely and effectively